Insider Trading & Ownership - Replimune Group Inc. (REPL)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Replimune Group Inc.
Goto Prev, 0, 1, 2, 3, 4
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-12-18
Sale
2020-12-22
4:38 pm
Replimune Group Inc. REPL Rhodes Jason P
Director
4,319 $41.95 $181,182 19,285
(Indirect)
View
2020-12-15
Sale
2020-12-17
6:21 pm
Replimune Group Inc. REPL Rhodes Jason P
Director
65,029 $42.28 $2,749,721 19,550
(Indirect)
View
2020-12-14
Sale
2020-12-16
9:00 pm
Replimune Group Inc. REPL Franchi Jean M.
Chief Financial Officer
25,000 $43.45 $1,086,200 155,000
(Direct)
View
2020-12-10
Sale
2020-12-14
7:20 pm
Replimune Group Inc. REPL Rhodes Jason P
Director
103,686 $43.35 $4,494,442 23,481
(Indirect)
View
2020-12-09
Sale
2020-12-11
9:00 pm
Replimune Group Inc. REPL Astley-Sparke Philip
Chief Executive Officer
50,000 $43.4 $2,169,874 1,305,297
(Direct)
View
2020-12-09
Sale
2020-12-11
9:00 pm
Replimune Group Inc. REPL Love Colin
Chief Operating Officer
30,000 $43.75 $1,312,382 976,524
(Direct)
View
2020-12-07
Sale
2020-12-09
7:54 pm
Replimune Group Inc. REPL Rhodes Jason P
Director
217,362 $45.92 $9,981,231 29,748
(Indirect)
View
2020-12-08
Sale
2020-12-09
7:50 pm
Replimune Group Inc. REPL SLATTERY JOSEPH P
Director
5,200 $46 $239,200 31,307
(Direct)
View
2020-12-07
Sale
2020-12-09
7:48 pm
Replimune Group Inc. REPL Dhingra Kapil
Director
40,000 $45.56 $1,822,395 3,169
(Direct)
View
2020-11-16
Sale
2020-11-18
8:00 pm
Replimune Group Inc. REPL Love Colin
Chief Operating Officer
15,000 $44.91 $673,649 1,006,524
(Direct)
View
2020-10-14
Sale
2020-10-16
6:05 pm
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
16,000 $32.9 $526,410 240,903
(Direct)
View
2020-09-15
Sale
2020-09-17
4:25 pm
Replimune Group Inc. REPL Love Colin
Chief Operating Officer
15,000 $23.97 $359,487 1,021,524
(Direct)
View
2020-08-31
Sale
2020-09-01
5:13 pm
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
5,000 $27.05 $135,250 256,903
(Direct)
View
2020-08-17
Sale
2020-08-18
5:15 pm
Replimune Group Inc. REPL Love Colin
Chief Operating Officer
15,000 $23.44 $351,555 1,036,524
(Direct)
View
2020-07-09
Sale
2020-07-10
9:00 pm
Replimune Group Inc. REPL Coffin Robert
President & Chief R&D Officer
169,750 $22.13 $3,757,295 2,024,118
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-12-14
Exercise
2020-12-16
9:00 pm
N/A
2029-12-09
Replimune Group Inc. REPL Franchi Jean M.
Chief Financial Officer
25,000 $0 155,000
(Direct)
View
2020-12-14
Exercise
2020-12-16
9:00 pm
N/A
N/A
Replimune Group Inc. REPL Franchi Jean M.
Chief Financial Officer
25,000 $14.08 155,000
(Direct)
View
2020-12-11
Exercise
2020-12-15
9:35 pm
N/A
2027-07-26
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
12,590 $0 246,981
(Direct)
View
2020-12-11
Exercise
2020-12-15
9:35 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
12,590 $3.3 246,981
(Direct)
View
2020-12-08
Exercise
2020-12-09
7:50 pm
N/A
2027-10-01
Replimune Group Inc. REPL SLATTERY JOSEPH P
Director
5,200 $0 31,307
(Direct)
View
2020-12-08
Exercise
2020-12-09
7:50 pm
N/A
N/A
Replimune Group Inc. REPL SLATTERY JOSEPH P
Director
5,200 $3.3 31,307
(Direct)
View
2020-12-07
Exercise
2020-12-09
7:48 pm
N/A
2026-01-21
Replimune Group Inc. REPL Dhingra Kapil
Director
40,000 $0 3,169
(Direct)
View
2020-12-07
Exercise
2020-12-09
7:48 pm
N/A
N/A
Replimune Group Inc. REPL Dhingra Kapil
Director
40,000 $1.75 3,169
(Direct)
View
2020-11-02
Option Award
2020-11-03
4:07 pm
N/A
2030-11-02
Replimune Group Inc. REPL Lewis Tanya
Director
33,000 $0 33,000
(Direct)
View
2020-10-14
Exercise
2020-10-16
6:05 pm
N/A
2025-11-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
16,000 $0 240,903
(Direct)
View
2020-10-14
Exercise
2020-10-16
6:05 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
16,000 $1.01 240,903
(Direct)
View
2020-09-15
Other
2020-09-17
4:48 pm
N/A
N/A
Replimune Group Inc. REPL Atlas Venture Fund X L.P.
10% Owner
445,339 $0 2,931,635
(Direct)
View
2020-08-31
Exercise
2020-09-01
5:13 pm
N/A
2025-11-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
5,000 $0 256,903
(Direct)
View
2020-08-31
Exercise
2020-09-01
5:13 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
5,000 $1.01 256,903
(Direct)
View
2020-07-20
Option Award
2020-07-22
08:14 am
N/A
2030-07-20
Replimune Group Inc. REPL Pirzkall Andrea
Chief Medical Officer
300,000 $0 300,000
(Direct)
View

Ownership
2020-07-22
08:13 am
N/A
N/A
Replimune Group Inc. REPL Pirzkall Andrea
Chief Medical Officer
0 $0 1,000
(Indirect)
View
2020-07-02
Other
2020-07-07
6:54 pm
N/A
N/A
Replimune Group Inc. REPL Atlas Venture Fund X L.P.
10% Owner
445,339 $0 3,376,974
(Direct)
View
2020-06-16
Other
2020-06-18
4:37 pm
N/A
N/A
Replimune Group Inc. REPL Atlas Venture Fund X L.P.
10% Owner
445,339 $0 3,822,313
(Direct)
View
Goto Prev, 0, 1, 2, 3, 4